Tenet Healthcare
Forecast impact
Track in portfolio
Price chart
Description
Company and Business Model
Tenet Healthcare is a leading healthcare services company that operates hospitals, outpatient centers, and ancillary services. Its core offerings include acute care services, surgical services, and rehabilitation. The company generates revenue primarily through patient services, including inpatient and outpatient care, as well as through partnerships with insurance providers. Tenet also engages in healthcare technology and management services, enhancing operational efficiency across its facilities.
Investment Profile
The investment profile of Tenet Healthcare suggests it is more aligned with growth investors due to its strong revenue growth and positive earnings surprises. The company's focus on expanding its service offerings and improving operational efficiencies positions it favorably for future performance. Investors may find it suitable for medium to long-term horizons, given its growth potential.
Fundamental metrics (experimental) Updated: 2026-09-07
- EPS (TTM) — earnings per share for the last 12 months, $
- 26.12
- Revenue QoQ — quarter-over-quarter revenue growth
- 4.8%
- EPS surprise
- 43.7%
- 20d volatility
- 1.5%
- last ex-date
- 2000-03-13
| Date | Before | After | Reason |
|---|---|---|---|
| 2026-07-25 | — | Buy | Strong momentum and earnings surprise indicate growth potential. |
| Date | Analyst | Action | Target | Price Then |
|---|---|---|---|---|
| 2026-08-14 | Raymond James | Target Raised | 275 → 285 | 267.27 |
| 2026-08-10 | Mizuho Securities | Target Raised | 250 → 290 | 262.13 |
| 2026-08-03 | Wells Fargo | Target Raised | 231 → 281 | 254.78 |
| 2026-07-28 | Goldman Sachs | Target Raised | 252 → 305 | 262.63 |
| 2026-07-28 | Truist Financial | Target Raised | 270 → 290 | 243.36 |
| 2026-07-28 | Robert W. Baird | Target Raised | 210 → 280 | 243.36 |
| 2026-07-27 | Stephens | Target Raised | 250 → 285 | 245.35 |
| 2026-07-27 | UBS | Target Raised | 288 → 308 | 245.61 |
| 2026-07-27 | Piper Sandler | Target Raised | — → 308 | 246.83501 |
| 2026-07-27 | Morgan Stanley | Target Raised | 254 → 274 | 243.89 |
| 2026-07-27 | Raymond James | Target Raised | — → 270 | 244.435 |
| 2026-07-27 | RBC Capital | Target Raised | 236 → 283 | 233.2 |
| 2026-07-24 | Barclays | Target Raised | 240 → 271 | 199.02 |
| 2026-07-20 | Guggenheim | Target Lowered | 252 → 242 | 194.91 |
| 2026-07-13 | Wells Fargo | Target Raised | 213 → 231 | 204.25 |
| 2026-05-05 | Robert W. Baird | Target Lowered | 245 → 210 | 185.35 |
| 2026-05-05 | Barclays | Target Lowered | 257 → 238 | 185.35 |
| 2026-05-04 | Stephens | Target Lowered | 275 → 260 | 183.27 |
| 2026-05-01 | Morgan Stanley | Target Lowered | 260 → 254 | 183.95 |
| 2026-03-12 | Guggenheim | Target Raised | — → 283 | 234.58 |
| 2026-02-17 | Truist Financial | Target Raised | 240 → 270 | 232.06 |
| 2026-02-16 | Wells Fargo | Target Raised | 229 → 265 | 231.1 |